Antares Pharma Inc (ATRS) Q1 Results Unimpressive, but Otrexup Could Be Catalyst
Antares Pharma Inc (NASDAQ:ATRS) announced its first-quarter results Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading. Here are the highlights from the...... (read more)






